lazucirnon (AKST4290) - Grifols
Rituxan (rituximab) - Biogen, Zenyaku Holdings, Roche
Coversin SC (nomacopan SC) - Akari Therap
Xolair (omalizumab) - Roche, Novartis
Ilumya (tildrakizumab-asmn) - Sun Pharma, Almirall
Cosentyx (secukinumab) - Novartis
bertilimumab (iCo-008) - Satellos Biosci, AstraZeneca
Dupixent (dupilumab) - Sanofi, Regeneron
avdoralimab (IPH5401) - Innate
Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio
http://www.ncbi.nlm.nih.gov/pubmed/38157140
 
Aikaterini Patsatsi; Kilian Eyerich; Meropi Karakioulaki
 
Jan 2, 2024
 
Prev Next